Delivery Order SPE2DR25D2011-SPE2DR26FADRR
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Butalbital-Acetaminophen-Caffeine 50-325-40mg tablets in quantities of 100 units. This is a competitively awarded, firm fixed price contract with no set-aside designation, valued at $1,474.20 and scheduled for completion by August 29, 2025. The product will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,714.19 to AmerisourceBergen Drug Corp for the supply of Butalbital-Acetaminophen-Caffeine 50-325-40 mg tablets (500 count) with a firm fixed price and completion date of August 27, 2025. This non-set-aside competitive award was made to AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor and healthcare solutions provider. The...
- The Defense Logistics Agency awarded a delivery order valued at $1,122.18 to AmerisourceBergen Drug Corp for the supply of Butalbital-Acetaminophen-Caffeine 50-325-40 mg tablets (500 count) on November 20, 2025, with an ultimate completion date of November 21, 2025. The contract utilizes firm fixed-price pricing and is not designated as a set-aside award, indicating it was competitively awarded. Performance will be executed at AmerisourceBergen's Corporate Office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $2,020.27 to AmerisourceBergen Drug Corp for the supply of Butalbital-Aspirin-Caffeine tablets (100-count package) on December 18, 2025, with completion scheduled for December 19, 2025. This competitive, non-set-aside delivery order utilizes firm fixed pricing and reflects the company's role as a critical pharmaceutical distributor supporting federal medical procurement. The place of performance is AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,072.62 to AmerisourceBergen Drug Corp for Butalbital-Aspirin-Caffeine tablets (100 count) on December 23, 2025, with ultimate completion scheduled for December 24, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on April 24, 2025, for the supply of Butalbital-Aspirin-Caffeine tablets (90-count packages) with a firm fixed price ceiling value of $1,504.80. The award is non-set-aside and represents a competitively awarded transaction under a delivery order contract structure. The product will be delivered to the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date...
- The Defense Logistics Agency awarded a delivery order valued at $9,373.17 to AmerisourceBergen Drug Corp for butalbital-acetaminophen-caffeine 50-325-40mg tablets (100 count) on July 29, 2025, with an ultimate completion date of July 30, 2025. This non-set-aside, competitively awarded contract was issued under firm fixed-price terms and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The product being supplied is a combination pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Butalbital-Aspirin-Caffeine tablets (100 count) valued at $1,269.33 with a firm fixed price. This competitively awarded, non-set-aside contract is scheduled for completion by November 10, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,516.31 to AmerisourceBergen Drug Corp for Butalbital-Aspirin-Caffeine tablets (90-count) on August 18, 2025, with completion scheduled for August 19, 2025. This competitively awarded, firm fixed-price contract is non-set-aside and will be performed at the company's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical vendor, serves as a prime...
- The Defense Logistics Agency awarded a delivery order valued at $1,012.85 to AmerisourceBergen Drug Corp for Butalbital-Acetaminophen-Caffeine-Codeine 50-300mg tablets (100 count) on August 20, 2025, with an ultimate completion date of August 21, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger...
- SPE2DR25D2011Indefinite Delivery Contract
- SPE2DR25D2011-SPE2DR26FADRRDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 29, 2025, for the supply of Butalbital-Acetaminophen-Caffeine 50-325-40mg tablets in a quantity of 100 units, valued at $1,615.32. This is a firm fixed-price delivery order with an ultimate completion date of December 30, 2025, representing a competitively awarded, non-set-aside procurement. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.9 million through December 2026. This prime contract vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. As a major pharmaceutical distributor serving the Defense Health Agency and other federal healthcare systems, AmerisourceBergen leverages this framework agreement to fulfill varied medication requirements across multiple therapeutic domains, with individual delivery orders structured at firm fixed prices ranging from small-value transactions to substantial orders exceeding $45,000.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 12/28/25 |